Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Maximal and submaximal exercise testing in heart failure

M Metra1, S Nodari, D Raccagni

  • 1Department of Cardiology, University of Brescia, Italy.

Journal of Cardiovascular Pharmacology
|September 10, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

In silico analysis of patient specific coagulation and flow effects on fibrin clot formation.

Scientific reports·2026
Same author

Retraction Note: Presence of viral spike protein and vaccinal spike protein in the blood serum of patients with long-COVID syndrome.

European review for medical and pharmacological sciences·2024
Same author

Serum proteomic profiling reveals potential inflammatory biomarkers in long-COVID patients: a comparative analysis with healthy controls.

European review for medical and pharmacological sciences·2023
Same author

Presence of viral spike protein and vaccinal spike protein in the blood serum of patients with long-COVID syndrome.

European review for medical and pharmacological sciences·2023
Same author

Linking pathogenic and likely pathogenic gene variants to long-COVID symptoms.

European review for medical and pharmacological sciences·2023
Same author

Autoantibodies in patients with post-COVID syndrome: a possible link with severity?

European review for medical and pharmacological sciences·2023
Same journal

Integration of Mendelian Randomization and FAERS Database Analysis Reveals the Association Between Ergotamine and Aortic and Mitral Valve Diseases.

Journal of cardiovascular pharmacology·2026
Same journal

A Comprehensive Review of PCSK9 Inhibitor Therapy.

Journal of cardiovascular pharmacology·2026
Same journal

SGLT2 Inhibitors and Progression of Chronic Kidney Disease in Patients with Elevated Lipoprotein(a): A Real-World Cohort Study.

Journal of cardiovascular pharmacology·2026
Same journal

Aspirin in primary prevention: a case for selective use.

Journal of cardiovascular pharmacology·2026
Same journal

GLP-1 Gene Therapy Trial for Obesity and Type 2 Diabetes: Towards a New Paradigm for Chronic Disease Treatment.

Journal of cardiovascular pharmacology·2026
Same journal

Expert Opinion: Restrictions, Precautions, or Normalcy? Defining Everyday Risk in Patients Treated With IL-1 Blockers for Recurrent Pericarditis.

Journal of cardiovascular pharmacology·2026
See all related articles

Measuring exercise capacity in congestive heart failure (CHF) is key. While peak VO2 is accurate for maximal capacity, submaximal tests may better reflect daily activity and therapy response in CHF patients.

Area of Science:

  • Cardiology
  • Exercise Physiology

Background:

  • Reduced exercise capacity is a primary symptom in congestive heart failure (CHF).
  • Current methods for measuring exercise capacity in CHF patients have limitations.
  • The optimal assessment strategy for functional capacity in CHF remains debated.

Purpose of the Study:

  • To review and compare different methods for measuring exercise capacity in patients with congestive heart failure.
  • To evaluate the suitability of various exercise testing parameters for assessing functional status and treatment efficacy in CHF.

Main Methods:

  • Review of maximal exercise testing (Peak VO2).
  • Analysis of anaerobic threshold as a functional capacity parameter.
  • Discussion of VO2 kinetics and submaximal exercise tests (e.g., 6-minute walk test).

Related Experiment Videos

Main Results:

  • Peak VO2 accurately measures maximal functional capacity but has low sensitivity for therapy-induced changes and poor correlation with daily activity and quality of life.
  • Anaerobic threshold indicates maximal cardiovascular effort but is indirectly assessed.
  • Submaximal tests show promise for therapy assessment but can be limited in multicenter trials and may overlap with maximal testing in severely limited patients.

Conclusions:

  • No single method perfectly captures exercise capacity in CHF patients.
  • Peak VO2 is a strong prognostic marker but limited for tracking therapy.
  • Further research is needed to optimize protocols for assessing exercise performance, symptoms, and therapy response in CHF.